InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-22.8%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Belloff Neil S., Chief Executive Officer. Insider active across 1 company, notably Eloxx Pharmaceuticals, Inc.. In total, 6 disclosures have been logged. Activity tracked since 30 April 2021. The latest transaction was filed on 30 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
1,563 shares0Common StockSEC:0001415889-21-003750:0
1,563 shares0Common StockSEC:0001415889-21-003750
6,250 shares0Common StockSEC:0001415889-21-002682:0
6,250 shares0Common StockSEC:0001415889-21-002682
1,562 shares0Common StockSEC:0001415889-21-002227
1,562 shares0Common StockSEC:0001415889-21-002227:0
6 of 6 declarations
About Belloff Neil S.
Neil S. Belloff is the Chief Operating Officer, General Counsel, and Corporate Secretary of Eloxx Pharmaceuticals, Inc. He oversees the daily operations of the company while ensuring legal and regulatory compliance. His role is crucial for navigating the complex and ever-evolving pharmaceutical sector.
